“…GBM has been shown to preferentially dysregulate inhibitory interneurons (Campbell et al, 2015), upregulate expression of glutamate exporters (de Groot & Sontheimer, 2011; Takano et al, 2001), activate microglia (Hatcher et al, 2020), and modify synaptogenesis (Lin et al, 2017; Venkatesh et al, 2019) in a tumor driver gene-specific manner (Yu et al, 2020). Reports of GBM-induced changes in neurovascular coupling and neural activity dysregulation using human glioma cells implanted in mouse cortex offer additional evidence that improved understanding of this malignant progression may enable novel therapeutic opportunities (Gill et al, 2022; Montgomery et al, 2020; Tantillo et al, 2020; Venkataramani et al, 2022). With each of these advances in defining downstream molecular and cellular defects, the complexity of GBM biology and its interrelationship with surrounding excitable cortical tissue continues to grow.…”